# Medivis

> Medivis develops medical imaging, surgical planning and navigation systems that combine augmented reality, computer vision and AI-assisted segmentation. Its Studio platform prepares patient-specific imaging, its FDA-cleared spine and cranial systems guide trained clinicians, and AnatomyX provides collaborative anatomy education. It sells to healthcare organizations and educational institutions.

- **Founded:** 2016
- **Headquarters:** New York, United States
- **Founders:** Osamah Choudhry (Co-founder and CEO; neurosurgeon), Christopher Morley (Co-founder and President; radiologist)
- **Products:** SurgicalAR, Medivis Studio, Spine Navigation, Cranial Navigation, AnatomyX
- **Notable:** 2019 FDA 510(k) clearance for the original imaging platform, K190764., TIME Best Inventions 2023 recognition for SurgicalAR., Named among Fast Company’s Most Innovative Companies of 2024.

## Products & services

- **SurgicalAR** — Original AR medical visualization platform launched in 2019; the imaging, segmentation and planning platform is now presented as Medivis Studio.
- **Medivis Studio** — FDA-cleared, CE-marked imaging, segmentation, 3D reconstruction and planning platform, with workstation and enterprise deployments. Current branding observed in October 2026; clearance K190764 dates to 2019.
- **Spine Navigation** — FDA-cleared image-guided system for open and percutaneous spine procedures, using registered imaging and tool tracking. Clearance July 26, 2024; US commercial launch announced April 2, 2025.
- **Cranial Navigation** — Image-guided cranial system cleared as NeuroAlign software on October 21, 2025; Medivis announced it in December 2025, positioning it for operating-room and bedside workflows.
- **AnatomyX** — Collaborative anatomy education with shared 3D models, custom prosections, quizzes and annual subscriptions; publicly available by 2019.
- **Body Navigation** — Investigational ultrasound and MRI fusion with tracked instruments, with prostate biopsy as a lead indication. Not FDA cleared or available for sale in the United States as of October 2026.
- **Frontier** — Research and co-development involving contextual AI agents and surgical robotics; not cleared commercial products.

## Achievements

- 2019 FDA 510(k) clearance for the original imaging platform, K190764.
- TIME Best Inventions 2023 recognition for SurgicalAR.
- Named among Fast Company’s Most Innovative Companies of 2024.
- Spine Navigation clearance on July 26, 2024, K233725.
- Cranial NeuroAlign software clearance on October 21, 2025, K231897.
- Current company site reports more than 3,000 surgeries and more than 50 clinical and educational deployments.

## Latest updates

- **2026-09** — AnatomyX Google Play listing updated September 1 with prosection highlighting options and visual/bug fixes.
- **2025-12** — Medivis announced cranial-navigation clearance and highlighted ICU and bedside use.
- **2025-04** — Medivis announced US commercial launch of Spine Navigation.

## Links

- Website: https://www.medivis.com/
- LinkedIn: https://www.linkedin.com/company/medivis-inc/
- Twitter/X: https://x.com/Medivis_AI
- YouTube: https://www.youtube.com/@medivisinc.4509
- Instagram: https://www.instagram.com/medivis_ai/
- Facebook: https://www.facebook.com/medivisinc/

---

Profile page: https://yespress.io/medivis
Published by YesPress — https://yespress.io
Last updated: 2026-10-05